55,985 results match your criteria Breast Cancer Male

Health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R-04.

Cancer 2022 Jun 24. Epub 2022 Jun 24.

NRG Oncology Statistics and Data Management Center, Pittsburgh, Pennsylvania, USA.

Background: There has been limited evaluation of health-related quality of life (HRQOL) in rectal cancer patients receiving neoadjuvant chemoradiotherapy. HRQOL outcomes in the National Surgical Adjuvant Breast and Bowel Project R-04 trial are examined in this article.

Methods: Between 2004 and 2010, R-04 patients were invited to enroll in the HRQOL substudy, with questionnaires administered before randomization, after completion of chemoradiotherapy, and 1-year after surgery. Read More

View Article and Full-Text PDF

Too Much Healthcare: The Harmful Combination of Overdiagnosis and Medical Overuse, Told and Untold Stories.

Anat Gaver

Isr Med Assoc J 2022 Jun;24(6):399-402

Department of Family Medicine, Dan and Tel Aviv Districts, Clalit Health Services, Ramat Gan, Israel.

Background: Too much healthcare is prevalent, wasteful, and harmful. It consists of two separate phenomena: overdiagnosis and overuse. Overdiagnosis is the labeling of a person with a disease or abnormal condition that would not have caused the person harm if left undiscovered. Read More

View Article and Full-Text PDF

Relationships between androgen receptor expression and clinicopathological parameters in male breast cancer.

Ann Ital Chir 2021 Nov 23;10. Epub 2021 Nov 23.

Introduction: Most patients with male breast cancer (MBC) express the androgen receptor (AR). AR expression in these tumors may have both prognostic and predictive values because its presence indicates the potential benefits of an anti-androgen therapeutic approach. The present study aimed to investigate the relationship between AR expression and clinicopathological parameters in MBC. Read More

View Article and Full-Text PDF
November 2021

Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.

Breast Cancer 2022 Jun 22. Epub 2022 Jun 22.

Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.

Background: Male breast cancer (MBC) is rare; however, its incidence is increasing. There have been no large-scale reports on the clinicopathological characteristics of MBC in Japan.

Methods: We investigated patients diagnosed with breast cancer in the Japanese National Clinical Database (NCD) between January 2012 and December 2018. Read More

View Article and Full-Text PDF

The Contribution of PDCD6 Polymorphisms to Oral Cancer Risk.

Cancer Genomics Proteomics 2022 Jul-Aug;19(4):456-463

Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;

Background/aim: Programmed cell death 6 (PDCD6) is up-regulated and highly expressed in early apoptotic cells. In several types of cancer, such as cervical, breast and lung cancers, the association of PDCD6 genotypes have been investigated. However, the contribution of PDCD6 variant genotypes to oral cancer has never been examined. Read More

View Article and Full-Text PDF

Considering hormone-sensitive cancers as a single disease in the UK biobank reveals shared aetiology.

Commun Biol 2022 Jun 21;5(1):614. Epub 2022 Jun 21.

Australian Centre for Precision Health, University of South Australia, Adelaide, SA, Australia.

Hormone-related cancers, including cancers of the breast, prostate, ovaries, uterine, and thyroid, globally contribute to the majority of cancer incidence. We hypothesize that hormone-sensitive cancers share common genetic risk factors that have rarely been investigated by previous genomic studies of site-specific cancers. Here, we show that considering hormone-sensitive cancers as a single disease in the UK Biobank reveals shared genetic aetiology. Read More

View Article and Full-Text PDF

Length of stay and cost of care associated with admissions for atrial fibrillation among patients with cancer.

BMC Cardiovasc Disord 2022 Jun 17;22(1):272. Epub 2022 Jun 17.

Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Background: The aim of this study is to assess the burden of AF-related hospitalizations inclusive of inflation-adjusted cost-of-care and length-of-stay (LOS) among cancer patients and the impact of direct current cardioversion (DCCV) on these outcomes.

Methods: Using the National Inpatient Sample (NIS), patients hospitalized with either a primary or secondary diagnosis of AF and comorbid cancer were identified and both cost of hospitalization and LOS were evaluated for each group. Subgroup analyses were performed for specific cancer types (breast, lung, colon, prostate and lymphoma), and those receiving DCCV. Read More

View Article and Full-Text PDF

A systematic literature review of the management, oncological outcomes and psychosocial implications of male breast cancer.

Eur J Surg Oncol 2022 Jun 10. Epub 2022 Jun 10.

University Hospital Wishaw, United Kingdom.

Background: Although male breast cancer (MBC) is a rare disease, accounting for <1% of all breast cancers, it has significant oncological, survival and psychosocial implications for patients. The aim of this study is to assess the latest literature in the diagnosis, management, oncological outcomes, and psychosocial impact of MBC.

Methods: A systematic literature review was conducted using the PRISMA guidelines (Moher et al. Read More

View Article and Full-Text PDF

A Japanese case of castration-resistant prostate cancer with BRCA2 and RB1 co-loss and TP53 mutation: a case report.

BMC Med Genomics 2022 Jun 20;15(1):138. Epub 2022 Jun 20.

Department of Urology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Background: Abnormalities in homologous recombination contribute to the aggressive nature of castration-resistant prostate cancer. Retinoblastoma transcriptional corepressor 1 (RB1) and breast cancer 2 (BRCA2) exist close to each other in the same chromosome, and the significance of their concurrent loss has become a hot topic in the field of cancer research.

Case Presentation: A 61-year-old man presented with a chief complaint of a mass on his head and was diagnosed as multiple bone metastases from prostate cancer. Read More

View Article and Full-Text PDF

Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma.

BMC Surg 2022 Jun 20;22(1):235. Epub 2022 Jun 20.

Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, 17th Tiyu Street, Wuhan, Hubei, 430060, The People's Republic of China.

Objective: It has been reported that papillary thyroid carcinoma (PTC) patients with lymph node metastasis (LNM) are largely associated with adverse outcomes. The present study aimed to assess the correlation between the number of metastatic lymph nodes (NMLNs) and clinical prognosis in patients with PTC.

Methods: We retrospectively reviewed the medical records of patients with PTC who underwent initial thyroid cancer surgery in Renmin Hospital of Wuhan University between 2017 and 2019. Read More

View Article and Full-Text PDF

Regional inequalities of tumour size at diagnosis in Germany: An ecological study in eight federal states.

Int J Cancer 2022 Jun 20. Epub 2022 Jun 20.

Institute of Social Medicine and Epidemiology, Brandenburg Medical School Theodor Fontane, Brandenburg an der Havel, Germany.

There is growing recognition of the importance of the residential environment for early detection of cancer. However, few studies have investigated area socioeconomic deprivation, social capital, and rurality in combination. Therefore, we aimed to estimate mutually adjusted associations of these characteristics with tumour size at diagnosis in Germany. Read More

View Article and Full-Text PDF

Non-cancer Causes of Death Following Initial Synchronous Bone Metastasis in Cancer Patients.

Front Med (Lausanne) 2022 2;9:899544. Epub 2022 Jun 2.

Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

Purpose: To investigate the non-cancer causes of death (COD) in cancer patients with synchronous bone metastasis (BM) that is based on the Surveillance, Epidemiology, and End Results (SEER) database.

Methods: The retrospective cohort study included malignant cancer patients with synchronous BM diagnosed from 2010 to 2018 in the SEER database. The frequencies and proportion of non-cancer COD were calculated and analyzed in different genders, ages, and races subgroups. Read More

View Article and Full-Text PDF

Abduction Deficit Mimicking Sixth Nerve Palsy due to Metastasis in Systemic Malignancy: Rare Case Report.

Middle East Afr J Ophthalmol 2021 Oct-Dec;28(4):263-266. Epub 2022 Apr 30.

Department of Ophthalmology, AIIMS, Bhubaneswar, Odisha, India.

Lateral rectus palsy presenting as abduction deficit resulting in diplopia is attributed to neurogenic causes. Metastasis as a cause of sixth cranial palsy is an extremely rare entity but cannot be overlooked. Cases of metastasis to lateral rectus secondary to lung and breast carcinoma have been reported. Read More

View Article and Full-Text PDF

Needs of cancer patients during the SARS-CoV-2 Omicron lockdown: A population-based survey in Shanghai, China.

Biosci Trends 2022 Jun 17. Epub 2022 Jun 17.

Shanghai Health Development Research Center, Shanghai Medical Information Center, Shanghai, China.

The aim of this study was to investigate the medical and healthcare needs of cancer patients during the Shanghai lockdown due to the SARS-CoV-2 Omicron pandemic. From April 15 to April 21, 2022, 4,195 cancer patients from every district in Shanghai were surveyed using quota sampling via an online platform. The questionnaire consisted of three main parts: demographic and sociological data, disease diagnosis, and different dimensions of patients' needs. Read More

View Article and Full-Text PDF

Prognostic implication of isolated pulmonary nodules in patients with a history of breast cancer.

J Cardiothorac Surg 2022 Jun 18;17(1):160. Epub 2022 Jun 18.

Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.

Background: Isolated malignant pulmonary nodules were frequently seen in patients with breast cancer. These were metastasis from the breast cancer or new primary lung cancer. The role of surgery for such pulmonary nodules remains unclear. Read More

View Article and Full-Text PDF

Surveillance mammography after treatment for male breast cancer.

Breast Cancer Res Treat 2022 Jun 17. Epub 2022 Jun 17.

Department of Oncology, Mayo Clinic, Rochester, MN, USA.

Purpose: To identify the practice patterns related to use of surveillance mammography in male breast cancer (MaBC) survivors.

Methods: Using administrative claims data from OptumLabs Data Warehouse, we identified men who underwent surgery for breast cancer during 2007-2017. We calculated the proportion of men who had at least one mammogram (a) within 13 months for all patients and (b) within 24 months amongst those who maintained their insurance coverage for at least that length of time after surgery. Read More

View Article and Full-Text PDF

Katanin subunits p60 and p80, potential biomarkers for papillary thyroid carcinoma to distinguish nodular goiter: STROBE.

Medicine (Baltimore) 2022 Jun 17;101(24):e29402. Epub 2022 Jun 17.

Institute of Biological Anthropology, Jinzhou Medical University, Jinzhou, Liaoning, China.

Abstract: Katanin subunits p60 and p80 are involved in microtubule-mediated cytoskeletal organization during cell division. Their aberrant expression has been found in prostate, breast, and non-small cell lung (NSCLC) cancers. It has recently been reported that compared with adjacent papillary thyroid carcinoma (PTC) tissues, both are highly expressed in tumor tissues. Read More

View Article and Full-Text PDF

Breast Tumor Detection Using Robust and Efficient Machine Learning and Convolutional Neural Network Approaches.

Comput Intell Neurosci 2022 7;2022:6333573. Epub 2022 Jun 7.

Department of Pharmacy Practice, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia.

Breast cancer develops when cells in the breast expand and divide uncontrollably, resulting in a lump of tissue known as a tumor. This lump of tissue is called a tumor. After skin cancer, breast cancer is the second most common cancer among women. Read More

View Article and Full-Text PDF

Postmastectomy Reconstruction in Male Breast Cancer.

Breast J 2022 29;2022:5482261. Epub 2022 Mar 29.

Department of Plastic & Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, DC, USA.

Introduction: Less than 1% of all breast cancers are diagnosed in males. In females, postmastectomy breast reconstruction is associated with increased patient satisfaction. However, there is a paucity of literature describing reconstructive options for postmastectomy deformity in the male chest. Read More

View Article and Full-Text PDF

Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers.

Commun Biol 2022 Jun 16;5(1):594. Epub 2022 Jun 16.

Queensland University of Technology, Centre for Genomics and Personalised Health, Faculty of Health, Kelvin Grove, QLD, Australia.

Aberrant DNA methylation has emerged as a hallmark in several cancers and contributes to risk, oncogenesis, progression, and prognosis. In this study, we performed imputation-based and conventional methylome-wide association analyses for breast cancer (BrCa) and prostate cancer (PrCa). The imputation-based approach identified DNA methylation at cytosine-phosphate-guanine sites (CpGs) associated with BrCa and PrCa risk utilising genome-wide association summary statistics (N = 228,951, N = 140,254) and prebuilt methylation prediction models, while the conventional approach identified CpG associations utilising TCGA and GEO experimental methylation data (N = 621, N = 241). Read More

View Article and Full-Text PDF

Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge-December 1st-2nd, 2021.

J Transl Med 2022 Jun 15;20(1):271. Epub 2022 Jun 15.

Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.

After the success of immunotherapy in the treatment of advanced metastatic cancer, further evaluation in earlier settings, including high-risk, surgically-resectable disease is underway. Potential benefits of a neoadjuvant immunotherapeutic approach include presurgical tumor shrinkage, reduced surgical morbidity, early eradication of micrometastases and prevention of distant disease, and greater antigen-specific T cell response. For some cancers, pathologic response has been established as a surrogate measure for long-term outcomes, therefore offering the ability for early and objective assessment of treatment efficacy and the potential to inform and personalize adjuvant treatment clinical decision-making. Read More

View Article and Full-Text PDF

Experiences of young Australian mothers with infant feeding.

BMC Pregnancy Childbirth 2022 Jun 15;22(1):489. Epub 2022 Jun 15.

School of Health Sciences, Western Sydney University, Locked Bag 1797, Penrith, NSW, 2751, Australia.

Background: Despite the overwhelming evidence of health and other benefits of breastfeeding and recommendations to breastfeed by peak health bodies, breastfeeding rates are significantly lower than recommended in Australia and globally. Young mothers are identified as being at high risk of not breastfeeding their infants according to infant feeding recommendations. This study aimed to gain an in-depth understanding of young Australian mothers' experiences of infant feeding, and to explore the factors which facilitated or hindered adherence to recommended breastfeeding practices. Read More

View Article and Full-Text PDF

[Construction of prediction model combined dual-energy CT quantitative parameters and conventional CT features for assessing the Ki-67 expression levels in invasive breast cancer].

Zhonghua Yi Xue Za Zhi 2022 Jun;102(23):1753-1759

Department of Radiology, Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.

To develop a model combined with dual-energy CT quantitative parameters and conventional CT features for evaluating the expression level of Ki-67 in invasive breast cancer. A total of 191 patients with histologically confirmed invasive breast cancer in Lishui Central Hospital from March 2019 to December 2020, were retrospectively enrolled, all of them were females, aged from 25 to 77 (53.2±11. Read More

View Article and Full-Text PDF

Hereditary hemochromatosis variant associations with incident non-liver malignancies: 11-year follow-up in UK Biobank.

Cancer Epidemiol Biomarkers Prev 2022 Jun 16. Epub 2022 Jun 16.

University of Exeter, Exeter, United Kingdom.

Background: In European ancestry populations, iron overload disorder Hereditary Hemochromatosis (HH) is predominantly caused by HFE p.C282Y and p.H63D mutations. Read More

View Article and Full-Text PDF

Pembrolizumab Induced Acute Kidney Injury and Liver Injury in a Patient with Malignant Melanoma.

S D Med 2022 Apr;75(4):162-165

Division of Transplant Hepatology, University of South Dakota Sanford School of Medicine.

Immune checkpoint inhibitors (ICIs) have recently gained recognition as valuable treatment options for a variety of cancers. Pembrolizumab is a monoclonal antibody that acts as an inhibitor of programmed cell death receptor-1 (PD-1). This helps release host T-cells from regulatory inhibition by tumor neoantigens, therefore mediating antitumor effects. Read More

View Article and Full-Text PDF

Diagnostic pitfall in a large cell lung cancer with testicular metastasis synchronous malignant pleural mesothelioma patient: A case report.

Thorac Cancer 2022 Jun 15. Epub 2022 Jun 15.

Department of Thoracic Surgery, Sichuan University West China Hospital, Chengdu, People's Republic of China.

Large cell lung cancer metastases to the testis are scarce, although it is the most common malignancy and the most common site of metastases for breast, colorectal and kidney cancers. We hereby report a 28-year-old male patient admitted to our hospital with a chief complaint of scrotal enlargement, accompanied by chest pain and progressive dyspnea. The definite diagnosis was malignant pleural mesothelioma with the synchronous occurrence of large cell lung cancer with testicular metastasis. Read More

View Article and Full-Text PDF

How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss.

Skin Appendage Disord 2022 May 10;8(3):245-248. Epub 2022 Jan 10.

Department of Dermatology, Alvaro Alvim School Hospital, Campos dos Goytacazes, Rio de Janeiro, Brazil.

Oral finasteride represented a breakthrough for treatment of male pattern hair loss (MPHL), with clinical studies having demonstrated high efficacy of treatment and a favorable safety profile. And yet, fertility issues, malignancy, and postfinasteride syndrome have been concerns of users and prescribers of the drug. Pre-existing mental health disorder may put patients at an increased risk of nocebo, while the prevalence of personality disorders in subjects with MPHL is known to be higher than in the general population, specifically histrionic personality disorder. Read More

View Article and Full-Text PDF

The androgen receptor messenger RNA: what do we know?

RNA Biol 2022 Jan;19(1):819-828

Department of Biological, Geo. and Evs. Sciences, Cleveland State University, Cleveland, OH, USA.

The Androgen Receptor (AR), transcriptionally activated by its ligands, testosterone and dihydrotestosterone (DHT), is widely expressed in cells and tissues, influencing normal biology and disease states. The protein product of the AR gene is involved in the regulation of numerous biological functions, including the development and maintenance of the normal prostate gland and of the cardiovascular, musculoskeletal and immune systems. Androgen signalling, mediated by AR protein, plays a crucial role in the development of prostate cancer (PCa), and is presumed to be involved in other cancers including those of the breast, bladder, liver and kidney. Read More

View Article and Full-Text PDF
January 2022

Male breast cancer presenting in accessory axillary breast.

J Clin Ultrasound 2022 Jun 15. Epub 2022 Jun 15.

Department of Radiology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.

We present a rare case of male axillary accessory breast cancer, which is extremely rare and is indistinguishable from lymphadenopathy and other malignancies, such as lymphoma and skin-derived tumors. Clinicians should consider accessory breast cancer in the differential diagnosis even in men, particularly in those who present with superficially located tumors with adjacent accessory breast tissue. Read More

View Article and Full-Text PDF

Contraception knowledge and practices among students in Lebanese universities.

J Biosoc Sci 2022 Jun 15:1-11. Epub 2022 Jun 15.

Department of Gynaecology, Faculty of Medicine, St Joseph University and Hôtel-Dieu de France University Hospital, Beirut, Lebanon.

This study aimed to evaluate the proportion of contraception users among Lebanese youth, and the extent of knowledge and perception on birth control; and to raise awareness and sensitise young adults to sexual health, which remains taboo in Lebanon. The 30-item questionnaire was broadcasted to students in private and public universities in Lebanon, through social media and it collected information on contraception use and student knowledge. Over 30% of responders were medical students, and 41% have ever used contraceptives (mostly women); among which, 52. Read More

View Article and Full-Text PDF